Meditrial

Meditrial is a privately held, full-service Clinical Research Organization (CRO) headquartered in New York with a significant operational presence in Europe. The company differentiates itself through a strong digital-first approach, offering proprietary software like the Catchtrial EDC system and ePRO/eCOA apps, alongside its Mastertrial e-learning platform for regulatory training. Its core business model is providing fee-for-service solutions across the entire product development lifecycle, from clinical trial execution to post-market compliance and reimbursement strategy, primarily serving pharmaceutical, medical device, biotech, and digital health companies. Meditrial's value proposition centers on using technology to reduce complexity, ensure data quality, and accelerate market access for its clients' therapies.

Proprietary digital platform including Catchtrial EDC (Electronic Data Capture) system, ePRO/eCOA mobile apps for patient data collection, and the Mastertrial e-learning platform for regulatory training.

Meditrial competes in the fragmented CRO and regulatory consulting market. It faces competition from large, full-service public CROs (e.g., IQVIA, ICON, Parexel) with vast resources, as well as from smaller, specialized regulatory and market access consultancies. Its key differentiators are its integrated tech platform (Catchtrial, Mastertrial) and its focus on serving as an official regulatory representative for multiple regions.